val-leu-arg-p-nitroanilide has been researched along with filipin in 1 studies
| Studies (val-leu-arg-p-nitroanilide) | Trials (val-leu-arg-p-nitroanilide) | Recent Studies (post-2010) (val-leu-arg-p-nitroanilide) | Studies (filipin) | Trials (filipin) | Recent Studies (post-2010) (filipin) |
|---|---|---|---|---|---|
| 28 | 0 | 0 | 767 | 0 | 105 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mueller, BM; Stahl, A | 1 |
1 other study(ies) available for val-leu-arg-p-nitroanilide and filipin
| Article | Year |
|---|---|
The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae.
Topics: Caveolin 1; Caveolins; Cell Fractionation; Cell Membrane; Chromogenic Compounds; Filipin; Glycosylphosphatidylinositols; Humans; Melanoma; Membrane Proteins; Nystatin; Octoxynol; Oligopeptides; Plasminogen; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 1995 |